Radiopharm Theranostics Limited (RAD.AX)
AUD 0.02
(-8.7%)
AUD 0.02
(-8.7%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 | 44.68 Million AUD | 52.14% |
| 2023 | 29.37 Million AUD | 43.84% |
| 2022 | 20.41 Million AUD | 12811.62% |
| 2021 | 158.14 Thousand AUD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 12.84 Million AUD | -37.1% |
| 2024 Q2 | 38.94 Million AUD | 203.25% |
| 2024 Q3 | 44.68 Million AUD | 14.72% |
| 2024 Q4 | 44.68 Million AUD | 0.0% |
| 2024 FY | 44.68 Million AUD | 52.14% |
| 2023 Q4 | 20.41 Million AUD | 54.34% |
| 2023 FY | 29.37 Million AUD | 43.84% |
| 2023 Q3 | 13.22 Million AUD | -39.71% |
| 2023 Q2 | 21.94 Million AUD | 58.05% |
| 2023 Q1 | 13.88 Million AUD | -32.0% |
| 2022 Q4 | 20.41 Million AUD | 159.16% |
| 2022 Q3 | 7.87 Million AUD | -55.3% |
| 2022 Q2 | 17.62 Million AUD | 182.8% |
| 2022 Q1 | 6.23 Million AUD | 0.0% |
| 2022 FY | 20.41 Million AUD | 12811.62% |
| 2021 FY | 158.14 Thousand AUD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| EZZ Life Science Holdings Limited | 4.22 Million AUD | -956.551% |
| Anatara Lifesciences Ltd | 306.84 Thousand AUD | -14461.905% |
| Zelira Therapeutics Limited | 9.35 Million AUD | -377.557% |
| Biome Australia Limited | 5.37 Million AUD | -731.581% |
| Patrys Limited | 691.36 Thousand AUD | -6363.02% |
| Orthocell Limited | 22.08 Million AUD | -102.345% |
| Imugene Limited | 33.14 Million AUD | -34.817% |
| Noxopharm Limited | 1.28 Million AUD | -3367.529% |
| PYC Therapeutics Limited | 10.18 Million AUD | -338.754% |
| Chimeric Therapeutics Limited | 12.8 Million AUD | -249.002% |
| Prescient Therapeutics Limited | 2.32 Million AUD | -1821.387% |
| Proteomics International Laboratories Limited | 1.62 Million AUD | -2648.162% |
| Cynata Therapeutics Limited | 1.17 Million AUD | -3715.624% |
| CSL Limited | 27.88 Billion AUD | 99.84% |
| Arovella Therapeutics Limited | 2.05 Million AUD | -2072.628% |
| Bio-Gene Technology Limited | 368.44 Thousand AUD | -12027.438% |
| Clinuvel Pharmaceuticals Limited | 28.11 Million AUD | -58.946% |
| Starpharma Holdings Limited | 8.69 Million AUD | -413.716% |
| Nanollose Limited | 465.64 Thousand AUD | -9495.991% |
| Memphasys Limited | 5.59 Million AUD | -698.997% |
| Invex Therapeutics Ltd | 431.63 Thousand AUD | -10252.167% |
| NeuroScientific Biopharmaceuticals Limited | 85.68 Thousand AUD | -52049.27% |
| Amplia Therapeutics Limited | 3.42 Million AUD | -1203.93% |
| Botanix Pharmaceuticals Limited | 3.73 Million AUD | -1097.271% |
| Island Pharmaceuticals Limited | 1.04 Million AUD | -4173.339% |
| Race Oncology Limited | 1.91 Million AUD | -2231.584% |
| Nyrada Inc. | 855.63 Thousand AUD | -5122.222% |
| Telix Pharmaceuticals Limited | 249.39 Million AUD | 82.083% |
| Dimerix Limited | 13.89 Million AUD | -221.622% |
| PharmAust Limited | 896.6 Thousand AUD | -4883.572% |
| Immutep Limited | 10.97 Million AUD | -306.964% |
| Clarity Pharmaceuticals Ltd | 8.33 Million AUD | -436.298% |
| Alterity Therapeutics Limited | 5.42 Million AUD | -723.547% |
| BTC Health Limited | 203.94 Thousand AUD | -21809.045% |
| Acrux Limited | 5.68 Million AUD | -685.705% |
| Neuren Pharmaceuticals Limited | 42.76 Million AUD | -4.49% |
| Biotron Limited | 737.5 Thousand AUD | -5958.654% |
| Tissue Repair Ltd | 1.35 Million AUD | -3207.641% |
| AdAlta Limited | 3.54 Million AUD | -1161.323% |
| Hexima Limited | 248.67 Thousand AUD | -17868.818% |
| AnteoTech Limited | 4.07 Million AUD | -996.448% |
| Paradigm Biopharmaceuticals Limited | 3.58 Million AUD | -1146.619% |
| Recce Pharmaceuticals Ltd | 15.89 Million AUD | -181.143% |
| Avecho Biotechnology Limited | 941.54 Thousand AUD | -4645.742% |
| Actinogen Medical Limited | 1.61 Million AUD | -2666.123% |
| Immuron Limited | 2.84 Million AUD | -1473.056% |
| Argenica Therapeutics Limited | 2.42 Million AUD | -1741.294% |